Recruiting Study of Ultomiris® (Ravulizumab) Safety in Pregnancy NCT06312644 Conditions Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +44 more Locations Research Site — Boston, Massachusetts, United States Research Site — Melbourne, Victoria, Australia Research Site — Paris, France Research Site — Essen, Norte-Westfalia, Germany View more locations Show fewer locations Loading locations... View Trial Details
